Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Revenue

In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M AUD with 88.85% growth. Rhythm Biosciences had revenue of 25.63K in the half year ending June 30, 2025, a decrease of -93.16%.

• Revenue: 3.19M
• Revenue Growth: +88.85%
• P/S Ratio: 9.91
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 31.63M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.19M	1.50M	88.85%
Jun 30, 2024	1.69M	-1.41M	-45.41%
Jun 30, 2023	3.10M	668.44K	27.54%
Jun 30, 2022	2.43M	1.32M	118.98%
Jun 30, 2021	1.11M	1.01M	1,008.51%